1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Molecular Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Hepatitis B Virus (HBV)
1.2.3 Hepatitis C Virus (HCV)
1.2.4 Human Immunodeficiency Virus (HIV)
1.2.5 Human Papillomavirus (HPV)
1.3 Market by Application
1.3.1 Global Viral Molecular Diagnostics Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Academics Institutions
1.3.4 Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Viral Molecular Diagnostics Market Perspective (2018-2030)
2.2 Viral Molecular Diagnostics Growth Trends by Region
2.2.1 Viral Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Viral Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Viral Molecular Diagnostics Forecasted Market Size by Region (2023-2030)
2.3 Viral Molecular Diagnostics Market Dynamics
2.3.1 Viral Molecular Diagnostics Industry Trends
2.3.2 Viral Molecular Diagnostics Market Drivers
2.3.3 Viral Molecular Diagnostics Market Challenges
2.3.4 Viral Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Molecular Diagnostics Players by Revenue
3.1.1 Global Top Viral Molecular Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Viral Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Viral Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Molecular Diagnostics Revenue
3.4 Global Viral Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Viral Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Molecular Diagnostics Revenue in 2022
3.5 Viral Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Viral Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Viral Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Molecular Diagnostics Breakdown Data by Type
4.1 Global Viral Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Viral Molecular Diagnostics Forecasted Market Size by Type (2023-2030)
5 Viral Molecular Diagnostics Breakdown Data by Application
5.1 Global Viral Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Viral Molecular Diagnostics Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Viral Molecular Diagnostics Market Size (2018-2030)
6.2 North America Viral Molecular Diagnostics Market Size by Country (2018-2023)
6.3 North America Viral Molecular Diagnostics Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Viral Molecular Diagnostics Market Size (2018-2030)
7.2 Europe Viral Molecular Diagnostics Market Size by Country (2018-2023)
7.3 Europe Viral Molecular Diagnostics Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Molecular Diagnostics Market Size (2018-2030)
8.2 Asia-Pacific Viral Molecular Diagnostics Market Size by Country (2018-2023)
8.3 Asia-Pacific Viral Molecular Diagnostics Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Viral Molecular Diagnostics Market Size (2018-2030)
9.2 Latin America Viral Molecular Diagnostics Market Size by Country (2018-2023)
9.3 Latin America Viral Molecular Diagnostics Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Molecular Diagnostics Market Size (2018-2030)
10.2 Middle East & Africa Viral Molecular Diagnostics Market Size by Country (2018-2023)
10.3 Middle East & Africa Viral Molecular Diagnostics Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboraories
11.1.1 Abbott Laboraories Company Detail
11.1.2 Abbott Laboraories Business Overview
11.1.3 Abbott Laboraories Viral Molecular Diagnostics Introduction
11.1.4 Abbott Laboraories Revenue in Viral Molecular Diagnostics Business (2018-2023)
11.1.5 Abbott Laboraories Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Viral Molecular Diagnostics Introduction
11.2.4 Bio-Rad Laboratories Revenue in Viral Molecular Diagnostics Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Becton, Dickinson
11.3.1 Becton, Dickinson Company Detail
11.3.2 Becton, Dickinson Business Overview
11.3.3 Becton, Dickinson Viral Molecular Diagnostics Introduction
11.3.4 Becton, Dickinson Revenue in Viral Molecular Diagnostics Business (2018-2023)
11.3.5 Becton, Dickinson Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Viral Molecular Diagnostics Introduction
11.4.4 Roche Revenue in Viral Molecular Diagnostics Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Gen-Probe
11.5.1 Gen-Probe Company Detail
11.5.2 Gen-Probe Business Overview
11.5.3 Gen-Probe Viral Molecular Diagnostics Introduction
11.5.4 Gen-Probe Revenue in Viral Molecular Diagnostics Business (2018-2023)
11.5.5 Gen-Probe Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Detail
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Viral Molecular Diagnostics Introduction
11.6.4 Qiagen Revenue in Viral Molecular Diagnostics Business (2018-2023)
11.6.5 Qiagen Recent Development
11.7 Olympus
11.7.1 Olympus Company Detail
11.7.2 Olympus Business Overview
11.7.3 Olympus Viral Molecular Diagnostics Introduction
11.7.4 Olympus Revenue in Viral Molecular Diagnostics Business (2018-2023)
11.7.5 Olympus Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Viral Molecular Diagnostics Introduction
11.8.4 Thermo Fisher Scientific Revenue in Viral Molecular Diagnostics Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
